Blackhouse G - Search Results

1

Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.

Goeree R, Bowen JM, Blackhouse G, Lazzam C, Cohen E, Chiu M, Hopkins R, Tarride JE, Tu JV. Goeree R, et al. Among authors: blackhouse g. Int J Technol Assess Health Care. 2009 Apr;25(2):196-207. doi: 10.1017/S0266462309090254. Epub 2009 Mar 31. Int J Technol Assess Health Care. 2009. PMID: 19331710

2

Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. TERMPROM Study Group. Term Prelabour Rupture of the Membranes.

Gafni A, Goeree R, Myhr TL, Hannah ME, Blackhouse G, Willan AR, Weston JA, Wang EE, Hodnett ED, Hewson SA, Farine D, Ohlsson A. Gafni A, et al. Among authors: blackhouse g. CMAJ. 1997 Dec 1;157(11):1519-25. CMAJ. 1997. PMID: 9400406 Free PMC article. Clinical Trial.

3

Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.

O'Brien BJ, Goeree R, Hux M, Iskedjian M, Blackhouse G, Gagnon M, Gauthier S. O'Brien BJ, et al. Among authors: blackhouse g. J Am Geriatr Soc. 1999 May;47(5):570-8. doi: 10.1111/j.1532-5415.1999.tb02572.x. J Am Geriatr Soc. 1999. PMID: 10323651

4

The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia.

Goeree R, O'Brien BJ, Blackhouse G, Agro K, Goering P. Goeree R, et al. Among authors: blackhouse g. Can J Psychiatry. 1999 Jun;44(5):455-63. doi: 10.1177/070674379904400505. Can J Psychiatry. 1999. PMID: 10389606

5

The economic burden of schizophrenia in Canada.

Goeree R, O'Brien BJ, Goering P, Blackhouse G, Agro K, Rhodes A, Watson J. Goeree R, et al. Among authors: blackhouse g. Can J Psychiatry. 1999 Jun;44(5):464-72. doi: 10.1177/070674379904400506. Can J Psychiatry. 1999. PMID: 10389607

6

Hospital selection for unit cost estimates in multicentre economic evaluations. Does the choice of hospitals make a difference?

Goeree R, Gafni A, Hannah M, Myhr T, Blackhouse G. Goeree R, et al. Among authors: blackhouse g. Pharmacoeconomics. 1999 Jun;15(6):561-72. doi: 10.2165/00019053-199915060-00004. Pharmacoeconomics. 1999. PMID: 10538329

7

Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis.

O'Brien B, Levine M, Willan A, Goeree R, Haley S, Blackhouse G, Gent M. O'Brien B, et al. Among authors: blackhouse g. Arch Intern Med. 1999 Oct 25;159(19):2298-304. doi: 10.1001/archinte.159.19.2298. Arch Intern Med. 1999. PMID: 10547169 Clinical Trial.

8

Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?

O'Brien BJ, Willan A, Blackhouse G, Goeree R, Cohen M, Goodman S. O'Brien BJ, et al. Among authors: blackhouse g. Am Heart J. 2000 Mar;139(3):423-9. doi: 10.1016/s0002-8703(00)90085-1. Am Heart J. 2000. PMID: 10689256 Clinical Trial.

9

Economic evaluation of long-term management strategies for erosive oesophagitis.

Goeree R, O'Brien B, Hunt R, Blackhouse G, Willan A, Watson J. Goeree R, et al. Among authors: blackhouse g. Pharmacoeconomics. 1999 Dec;16(6):679-97. doi: 10.2165/00019053-199916060-00007. Pharmacoeconomics. 1999. PMID: 10724795

10

Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS).

O'Brien BJ, Connolly SJ, Goeree R, Blackhouse G, Willan A, Yee R, Roberts RS, Gent M. O'Brien BJ, et al. Among authors: blackhouse g. Circulation. 2001 Mar 13;103(10):1416-21. doi: 10.1161/01.cir.103.10.1416. Circulation. 2001. PMID: 11245646 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters